Management Options for Linear Immunoglobulin A (IgA) Bullous Dermatosis: A Literature Review.
Khan M, Park L, Skopit S.
Cureus. 2023 Mar 21;15(3):e36481. doi: 10.7759/cureus.36481. eCollection 2023 Mar.
[Linear IgA bullous dermatosis].
Juratli HA, Sárdy M.
Hautarzt. 2019 Apr;70(4):254-259. doi: 10.1007/s00105-019-4377-9.
Linear IgA Bullous Dermatosis.
Nogueira BL, Heck R.
J Cutan Med Surg. 2022 Nov-Dec;26(6):640. doi: 10.1177/12034754221088563. Epub 2022 Mar 23.
Atezolizumab-induced linear IgA bullous dermatosis.
Aguilar-Duran S, Mee J, Popat S, Heelan K.
Br J Dermatol. 2022 Dec;187(6):e193. doi: 10.1111/bjd.21653. Epub 2022 Jun 7.
Vancomycin-induced linear IgA bullous dermatosis.
Navarro-Bielsa A, Abadías-Granado I, Gomez-Mateo MC, Gilaberte Y.
Med Clin (Barc). 2022 Jul 22;159(2):107. doi: 10.1016/j.medcli.2022.01.012. Epub 2022 Jun 2.
Linear IgA bullous dermatosis associated with ulcerative colitis: A case report and literature review.
Kanda N, Nakadaira N, Otsuka Y, Ishii N, Hoashi T, Saeki H.
Australas J Dermatol. 2020 Feb;61(1):e82-e86. doi: 10.1111/ajd.13121. Epub 2019 Jul 18.
Linear IgA Bullous Dermatosis.
Vico-Alonso C, Palencia-Pérez S.
N Engl J Med. 2020 Jun 4;382(23):2248. doi: 10.1056/NEJMicm1913412.
Linear IGA Dermatosis.
Bernett CN, Fong M, Yadlapati S, Rosario-Collazo JA.
2023 Aug 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Linear IgA bullous dermatosis after COVID-19 vaccination.
Zou H, Daveluy S.
Int J Dermatol. 2023 Feb;62(2):e56-e58. doi: 10.1111/ijd.16541. Epub 2022 Dec 5.
Linear IgA bullous dermatosis secondary to piperacillin-tazobactam.
Garcia-Mouronte E, Dominguez-Santas M, Bueno-Sacristan D, Azcarraga-Llobet C, Berna-Rico ED, de Nicolas-Ruanes MB, Moreno Garcia-Del Real C.
Dermatol Ther. 2022 Feb;35(2):e15232. doi: 10.1111/dth.15232. Epub 2021 Dec 1.
